Efficient killing of SW480 colon carcinoma cells by a signal transducer and activator of transcription (STAT) 3 hairpin decoy oligodeoxynucleotide - Interference with interferon-γ-STAT1-mediated killing

FEBS Journal

Volumn 276, Issue 9, 2009, Pages 2505-2515

  Tadlaoui Hbibi, Ali ^b,c   Laguillier, Christelle ^b,c   Souissi, Inès ^b,c   Lesage, Denis ^b,c   Le Coquil, Stéphanie ^b,c   Cao, An ^d   Metelev, Valeri ^e   Baran Marszak, Fanny ^a,b,c   Fagard, Remi ^a,b,c  

^a AVICENNE HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ PARIS 13   (France)

^d CNRS   (France)

^e MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Cell death; Hairpin decoy oligonucleotide; Interferon ; STAT1; STAT3

Indexed keywords

ACTIN; CYCLIN D1; GAMMA INTERFERON; HAIRPIN DECOY OLIGODEOXYNUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OLIGODEOXYNUCLEOTIDE; STAT1 PROTEIN; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL KILLING; CELL NUCLEUS; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; CYTOPLASM; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN LOCALIZATION; REPORTER GENE;

BINDING SITES; CARCINOMA; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; INTERFERON-GAMMA; OLIGODEOXYRIBONUCLEOTIDES; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 64149102805     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.06975.x     Document Type: Article

References (44)

1. Benekli M, Baer MR, Baumann H Wetzier M (2003) Signal transducer and activator of transcription proteins in leukemias. Blood 101, 2940 2954.
2. Zhong Z, Wen Z Darnell JE Jr. (1994) Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264, 95 98.
3. Park OK, Schaefer TS Nathans D (1996) In vitro activation of Stat3 by epidermal growth factor receptor kinase. Proc Natl Acad Sci USA 93, 13704 13708.
4. Coffer PJ Kruijer W (1995) EGF receptor deletions define a region specifically mediating STAT transcription factor activation. Biochem Biophys Res Commun 210, 74 81.
5. Shao H, Cheng HY, Cook RG Tweardy DJ (2003) Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res 63, 3923 3930.
6. Fujitani Y, Nakajima K, Kojima H, Nakae K, Takeda T Hirano T (1994) Transcriptional activation of the IL-6 response element in the junB promoter is mediated by multiple Stat family proteins. Biochem Biophys Res Commun 202, 1181 1187.
7. Bromberg J Darnell JE Jr. (2000) The role of STATs in transcriptional control and their impact on cellular function. Oncogene 19, 2468 2473.
8. Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S et al. (2001) Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells. Oncogene 20, 2499 2513.
9. Kanda N, Seno H, Konda Y, Marusawa H, Kanai M, Nakajima T, Kawashima T, Nanakin A, Sawabu T, Uenoyama Y et al. (2004) STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23, 4921 4929.
10. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C Darnell JE (1999) STAT3 as an oncogene. Cell 98, 295 303.
11. Epling-Burnette PK, Zhong B, Bai F, Jiang K, Bailey RD, Garcia R, Jove R, Djeu JY, Loughran TP Jr. Wei S (2001) Cooperative regulation of Mcl-1 by Janus kinase-stat and phosphatidylinositol 3-kinase contribute to granulocyte- macrophage colony-stimulating factor-delayed apoptosis in human neutrophils. J Immunol 166, 7486 7495.
12. Adachi Y, Aoki C, Yoshio-Hoshino N, Takayama K, Curiel DT Nishimoto N (2006) Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Int J Cancer 119, 1303 1311.
13. Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D et al. (2004) Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nat Med 10, 48 54.
14. Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y Kim JD (2000) Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. Proc Natl Acad Sci USA 97, 4227 4232.
15. Konnikova L, Kotecki M, Kruger MM Cochran BH (2003) Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer 3, 23.
16. Nagel-Wolfrum K, Buerger C, Wittig I, Butz K, Hoppe-Seyler F Groner B (2004) The interaction of specific peptide aptamers with the DNA binding domain and the dimerization domain of the transcription factor Stat3 inhibits transactivation and induces apoptosis in tumor cells. Mol Cancer Res 2, 170 182.
17. Turkson J, Ryan D, Kim JS, Zhang Y, Chen Z, Haura E, Laudano A, Sebti S, Hamilton AD Jove R (2001) Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem 276, 45443 45455.
18. Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF et al. (2003) Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci USA 100, 4138 4143.
19. Barton BE, Murphy TF, Shu P, Huang HF, Meyenhofer M Barton A (2004) Novel single-stranded oligonucleotides that inhibit signal transducer and activator of transcription 3 induce apoptosis in vitro and in vivo in prostate cancer cell lines. Mol Cancer Ther 3, 1183 1191.
20. Tomita T, Takano H, Tomita N, Morishita R, Kaneko M, Shi K, Takahi K, Nakase T, Kaneda Y, Yoshikawa H et al. (2000) Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis. Rheumatology (Oxford) 39, 749 757.
21. Nakamura H, Aoki M, Tamai K, Oishi M, Ogihara T, Kaneda Y Morishita R (2002) Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC-Nga atopic mouse model. Gene Ther 9, 1221 1229.
22. Liu X, Li J Zhang J (2007) STAT3-decoy ODN inhibits cytokine autocrine of murine tumor cells. Cell Mol Immunol 4, 309 313.
23. Bromberg JF, Horvath CM, Wen Z, Schreiber RD Darnell JE Jr. (1996) Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc Natl Acad Sci USA 93, 7673 7678.
24. Bromberg JF, Fan Z, Brown C, Mendelsohn J Darnell JE Jr. (1998) Epidermal growth factor-induced growth inhibition requires Stat1 activation. Cell Growth Differ 9, 505 512.
25. Chin YE, Kitagawa M, Kuida K, Flavell RA Fu XY (1997) Activation of the STAT signaling pathway can cause expression of caspase 1 and apoptosis. Mol Cell Biol 17, 5328 5337.
26. Lin Q, Lai R, Chirieac LR, Li C, Thomazy VA, Grammatikakis I, Rassidakis GZ, Zhang W, Fujio Y, Kunisada K et al. (2005) Constitutive activation of JAK3-STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3-STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am J Pathol 167, 969 980.
27. Kunnumakkara AB, Anand P Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269, 199 225.
28. Lin JK (2007) Molecular targets of curcumin. Adv Exp Med Biol 595, 227 243.
29. Schust J, Sperl B, Hollis A, Mayer TU Berg T (2006) Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. Chem Biol 13, 1235 1242.
30. Laguillier C, Hbibi AT, Baran-Marszak F, Metelev V, Cao A, Cymbalista F, Bogdanov A Jr. Fagard R (2007) Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide. FEBS Lett 581, 1143 1150.
31. Geller J, Petak I, Szucs KS, Nagy K, Tillman DM Houghton JA (2003) Interferon-gamma-induced sensitization of colon carcinomas to ZD9331 targets caspases, downstream of Fas, independent of mitochondrial signaling and the inhibitor of apoptosis survivin. Clin Cancer Res 9, 6504 6515.
32. Geller JI, Szekely-Szucs K, Petak I, Doyle B Houghton JA (2004) P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells. Cancer Res 64, 6296 6303.
33. Bene A, Kurten RC Chambers TC (2004) Subcellular localization as a limiting factor for utilization of decoy oligonucleotides. Nucleic Acids Res 32, e142.
34. Regis G, Pensa S, Boselli D, Novelli F Poli V (2008) Ups & downs: The STAT1:STAT3 seesaw of Interferon and gp130 receptor signalling. Semin Cell Dev Biol 19, 351 359.
35. Holschermann H, Stadlbauer TH, Wagner AH, Fingerhuth H, Muth H, Rong S, Guler F, Tillmanns H Hecker M (2006) STAT-1 and AP-1 decoy oligonucleotide therapy delays acute rejection and prolongs cardiac allograft survival. Cardiovasc Res 71, 527 536.
36. Stojanovic T, Scheele L, Wagner AH, Middel P, Bedke J, Lautenschlager I, Leister I, Panzner S Hecker M (2007) STAT-1 decoy oligonucleotide improves microcirculation and reduces acute rejection in allogeneic rat small bowel transplants. Gene Ther 14, 883 890.
37. Huckel M, Schurigt U, Wagner AH, Stockigt R, Petrow PK, Thoss K, Gajda M, Henzgen S, Hecker M Brauer R (2006) Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res Ther 8, R17.
38. Wagner AH, Wittjen I, Stojanovic T, Middel P, Meingassner JG Hecker M (2008) Signal transducer and activator of transcription 1 decoy oligodeoxynucleotide suppression of contact hypersensitivity. J Allergy Clin Immunol 121, 158 165.
39. Lui VW, Boehm AL, Koppikar P, Leeman RJ, Johnson D, Ogagan M, Childs E, Freilino M Grandis JR (2007) Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1. Mol Pharmacol 71, 1435 1443.
40. Ozaki Y, Edelstein MP Duch DS (1988) Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. Proc Natl Acad Sci USA 85, 1242 1246.
41. Stephanou A (2004) Role of STAT-1 & STAT-3 in ischaemia-reperfusion injury. Cell J Mol Med 8, 519 525.
42. Hilfiker-Kleiner D, Hilfiker A Drexler H (2005) Many good reasons to have STAT3 in the heart. Pharmacol Ther 107, 131 137.
43. Gariboldi MB, Ravizza R, Molteni R, Osella D, Gabano E Monti E (2007) Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Cancer Lett 258, 181 188.
44. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A Pestell RG (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270, 23589 23597.